600329.SS
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
ShanghaiCNYEQUITY
DELAYED
Last price
35.36
▼ 0.92 (2.54%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
36.05
Prev close
36.28
Day high
36.18
Day low
35.32
Volume
3.13M
Market cap
—
P/E (TTM)
—
52W range
34.70 – 50.95
Day trading desk
Gap from prior close
-0.63%
Prior close 36.28
VWAP
35.47
-0.30% from price
Relative volume
—
—
Session range
2.15%
35.32 – 36.08
Position in range
5%
Near session low
ATR (14D)
0.76
2.14% of price
Prior day high
36.46
PDH
Prior day low
35.70
PDL
Bid / ask spread
—
Quote not published
Session volume
3.04M
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.27%
-0.9%
1M
-5.78%
-9.5%
3M
-11.51%
-14.6%
6M
-24.56%
-35.6%
YTD
-22.51%
-34.8%
1Y
-11.18%
-31.2%
3Y
-13.25%
-87.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on 600329.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.92B | $7.31B | $8.22B | $8.25B | -32.7% |
| Operating revenue | $4.92B | $7.31B | $8.22B | $8.25B | -32.7% |
| Cost of revenue | $1.28B | $3.79B | $4.60B | $4.96B | -66.3% |
| Gross profit | $3.64B | $3.52B | $3.62B | $3.29B | +3.4% |
| Research & development | $189.81M | $162.38M | $184.63M | $153.15M | +16.9% |
| Selling, general & admin | $1.79B | $1.72B | $1.78B | $1.67B | +3.9% |
| Total operating expense | $2.67B | $2.67B | $2.75B | $2.57B | +0.1% |
| Operating income | $971.15M | $855.21M | $868.25M | $723.34M | +13.6% |
| Net interest income | $31.50M | -$13.45M | $16.76M | $42.21M | +334.2% |
| Pre-tax income | $2.49B | $2.58B | $1.10B | $980.19M | -3.5% |
| Tax provision | $376.70M | $363.56M | $126.66M | $106.93M | +3.6% |
| Net income | $2.13B | $2.23B | $986.71M | $861.79M | -4.4% |
| Net income to common | $2.13B | $2.23B | $986.71M | $861.79M | -4.4% |
| Basic EPS | 2.77 | 2.90 | 1.28 | 1.12 | -4.5% |
| Diluted EPS | 2.77 | 2.89 | 1.28 | 1.11 | -4.2% |
| EBIT | $2.50B | $2.62B | $1.13B | $990.46M | -4.7% |
| EBITDA | $2.61B | $2.74B | $1.26B | $1.11B | -4.8% |
| Basic shares | 769.32M | 768.74M | 770.87M | 769.46M | +0.1% |
| Diluted shares | 769.32M | 771.40M | 770.87M | 776.39M | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.02B | $2.94B | $2.13B | $2.88B | -65.5% |
| Cash & short-term investments | $1.02B | $2.94B | $2.13B | $2.88B | -65.5% |
| Accounts receivable | $973.20M | $756.29M | $2.17B | $2.15B | +28.7% |
| Inventory | $1.13B | $1.29B | $1.57B | $1.43B | -11.9% |
| Total current assets | $7.15B | $6.61B | $6.55B | $7.25B | +8.3% |
| Property, plant & equipment | $1.14B | $1.39B | $1.44B | $1.46B | -18.1% |
| Goodwill & intangibles | $311.15M | $349.92M | $396.74M | $376.82M | -11.1% |
| Total assets | $11.69B | $10.77B | $10.23B | $10.16B | +8.6% |
| Total current liabilities | $4.51B | $2.82B | $3.23B | $3.33B | +59.9% |
| Current debt | $57.90M | $21.65M | $81.80M | $101.64M | +167.4% |
| Long-term debt | — | — | $241.03M | $151.30M | — |
| Total debt | $65.68M | $28.59M | $329.14M | $257.91M | +129.8% |
| Total liabilities | $4.59B | $2.92B | $3.58B | $3.61B | +57.3% |
| Retained earnings | $4.89B | $5.64B | $4.39B | $4.26B | -13.2% |
| Shareholder equity | $7.10B | $7.84B | $6.60B | $6.52B | -9.5% |
| Working capital | $2.65B | $3.79B | $3.32B | $3.91B | -30.1% |
| Net tangible assets | $6.79B | $7.49B | $6.20B | $6.14B | -9.4% |
| Shares issued | 770.09M | 770.16M | 770.16M | 773.44M | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.11B | $2.22B | $968.71M | $873.26M | -4.7% |
| Depreciation & amortisation | $115.66M | $125.94M | $130.13M | $116.56M | -8.2% |
| Change in working capital | -$288.14M | $277.07M | -$206.51M | -$120.14M | -204.0% |
| Operating cash flow | $461.07M | $924.67M | $688.49M | $677.25M | -50.1% |
| Capital expenditure | -$118.61M | -$117.81M | -$140.93M | -$107.90M | -0.7% |
| Investing cash flow | -$1.41B | $342.31M | -$568.91M | -$12.28M | -511.3% |
| Dividends paid | -$981.29M | -$1.01B | -$877.33M | -$387.43M | +2.9% |
| Financing cash flow | -$980.88M | -$319.89M | -$833.77M | -$236.62M | -206.6% |
| Free cash flow | $342.45M | $806.86M | $547.56M | $569.34M | -57.6% |
| End cash position | $1.02B | $2.94B | $2.00B | $2.71B | -65.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.52B | $1.25B | $1.20B | $1.46B | $1.70B | +21.5% |
| Operating revenue | $1.52B | $1.25B | $1.20B | $1.46B | $1.70B | +21.5% |
| Cost of revenue | $337.79M | $359.32M | $290.84M | $380.47M | $922.59M | -6.0% |
| Gross profit | $1.18B | $888.15M | $904.38M | $1.07B | $773.21M | +32.6% |
| Research & development | $29.81M | $85.19M | $35.77M | $25.78M | $63.58M | -65.0% |
| Selling, general & admin | $625.03M | $67.00M | $273.53M | $630.67M | -$98.84M | +832.9% |
| Total operating expense | $675.51M | $798.83M | $622.93M | $675.60M | $706.64M | -15.4% |
| Operating income | $501.91M | $89.33M | $281.46M | $399.23M | $66.58M | +461.9% |
| Net interest income | -$142.01K | $2.03M | -$950.63K | $461.17K | -$7.60M | -107.0% |
| Pre-tax income | $494.29M | -$32.76M | $1.83B | $436.69M | $1.66B | +1,608.9% |
| Tax provision | $71.23M | $2.71M | $279.03M | $64.90M | $233.29M | +2,530.3% |
| Net income | $423.80M | -$21.16M | $1.55B | $374.25M | $1.43B | +2,102.8% |
| Net income to common | $423.80M | -$21.16M | $1.55B | $374.25M | $1.43B | +2,102.8% |
| Basic EPS | 0.55 | — | — | 0.49 | — | — |
| Diluted EPS | 0.55 | — | — | 0.49 | — | — |
| EBIT | $497.30M | -$30.44M | $1.83B | $439.35M | $1.67B | +1,733.8% |
| EBITDA | $497.30M | -$30.44M | $1.83B | $439.35M | $1.67B | +1,733.8% |
| Basic shares | 770.55M | — | — | 763.77M | — | — |
| Diluted shares | 770.55M | — | — | 763.77M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $902.12M | $1.02B | — | $3.63B | $1.45B | $2.94B | -11.2% |
| Cash & short-term investments | $902.12M | $1.02B | — | $3.63B | $1.45B | $2.94B | -11.2% |
| Accounts receivable | $1.28B | $973.20M | — | $1.23B | $1.09B | $756.29M | +31.5% |
| Inventory | $1.08B | $1.13B | — | $1.22B | $1.20B | $1.29B | -4.9% |
| Total current assets | $6.12B | $7.15B | — | $8.15B | $5.70B | $6.61B | -14.5% |
| Property, plant & equipment | $1.13B | $1.14B | — | $1.33B | $1.38B | $1.39B | -0.9% |
| Goodwill & intangibles | $307.19M | $311.15M | — | $341.05M | $345.47M | $349.92M | -1.3% |
| Total assets | $10.44B | $11.69B | — | $12.85B | $11.17B | $10.77B | -10.7% |
| Total current liabilities | $2.83B | $4.51B | — | $3.95B | $2.85B | $2.82B | -37.2% |
| Current debt | $47.56M | $57.90M | — | $6.97M | $72.43M | $21.65M | -17.9% |
| Total debt | $57.84M | $65.68M | — | $12.74M | $78.88M | $28.59M | -11.9% |
| Total liabilities | $2.91B | $4.59B | — | $4.05B | $2.95B | $2.92B | -36.5% |
| Retained earnings | $5.32B | $4.89B | — | $6.58B | $6.01B | $5.64B | +8.7% |
| Shareholder equity | $7.52B | $7.10B | — | $8.78B | $8.22B | $7.84B | +6.0% |
| Working capital | $3.29B | $2.65B | — | $4.20B | $2.85B | $3.79B | +24.1% |
| Net tangible assets | $7.22B | $6.79B | — | $8.44B | $7.87B | $7.49B | +6.3% |
| Shares issued | 770.09M | 770.09M | 770.09M | 770.09M | 770.16M | — | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$16.40M | -$55.73M | -$17.81M | -$24.00M | -$38.03M | +70.6% |
| Investing cash flow | $1.34B | $98.52M | $2.04B | -$1.85B | $1.52B | +1,262.8% |
| Dividends paid | -$1.88B | -$138.39K | -$16.36K | -$16.00K | -$27.43M | -1,356,274.9% |
| Financing cash flow | -$1.88B | -$1.35M | -$768.27K | -$223.19K | -$288.37M | -138,776.3% |
| Free cash flow | $405.77M | -$185.00M | $114.41M | $331.52M | $319.03M | +319.3% |
| End cash position | $901.89M | $1.02B | $3.63B | $1.45B | $2.94B | -11.3% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36.30
-2.58% from price
SMA 20
36.90
-4.21% from price
SMA 50
37.73
-6.31% from price
SMA 100
39.27
-9.95% from price
SMA 200
42.23
-16.30% from price
EMA 12
36.36
-2.74% from price
EMA 26
37.00
-4.42% from price
EMA 50
37.78
-6.41% from price
RSI (14)
36.3
Neutral
MACD (12,26,9)
-0.64
Hist -0.11
ATR (14)
0.76
2.14% of price
Realised vol 30D
27.6%
Annualised
Bollinger upper
38.59
20, 2σ
Bollinger lower
35.22
20, 2σ
50 / 200 cross
Death
37.73 vs 42.23
Trend bias
Below 200
-16.30%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.21
Less volatile than market
Correlation to SPY
-0.08
Largely independent
Realised vol 30D
27.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.4%
Peak to trough
Max drawdown 5Y
-55.1%
Peak to trough
ATR 14
0.76
2.14% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Sergio V. Crowley Publishes Operations Research Framework for Industrial Capital Deployment
TMX Newsfile · 9m ago
Two Dropbox Executives Sold After Their Shares Vested Last Week. The Future Sole CEO Wasn't One of Them
Motley Fool · 13m ago
One of Exxon's Biggest Oil Fields Is Running Out of Room to Grow. Here's Why That's Not a Crisis.
Motley Fool · 13m ago
Can Hershey step up to buy Mondelez?
Investing.com · 15m ago
Iconic bank stock pays Buffett's Berkshire $619M in annual dividends
TheStreet · 15m ago
BNP PARIBAS GROUP: SUDAN LITIGATION STATEMENT FROM BNP PARIBAS
GlobeNewswire · 16m ago
Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here’s Why.
24/7 Wall St. · 18m ago
Seahawks' Montorie Foster Jr. brings his Super Bowl ring to open houses after getting his real estate license
Moneywise · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.